Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FG7VL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,262
Award facts
- Contract value 100% obligated
- $21,262.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $21,262.38 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors. The contract is structured as a firm fixed price delivery order with a completion date of July 22, 2025, and was awarded on July 21, 2025. This award represents a non-competitive, sole-source delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a billion-dollar pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier to the Defense Logistics Agency's medical supply chain, providing a comprehensive range of brand-name and generic pharmaceuticals, vaccines, and medical devices to support military healthcare systems. Dupixent is a prescription biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma in eligible patient populations. As a child delivery order under the DLA Troop Support Medical IDC, this award leverages the established prime vendor relationship to ensure rapid procurement and delivery of specialized pharmaceutical products to support Defense Health Agency and military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FG7VL?
SPE2DB25FG7VL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FG7VL worth?
The government has obligated $21,262 on SPE2DB25FG7VL.
Is contract SPE2DB25FG7VL an order under another contract?
Yes. SPE2DB25FG7VL is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG7VL competed?
The extent of competition for SPE2DB25FG7VL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award